From cutting-edge therapeutics to 5G-enabled healthcare, BIO Asia–Taiwan 2025 showcased an industry in rapid transformation—reflecting global shifts in science, regulation, and market dynamics. Over 900 companies, policymakers, and researchers gathered to explore how AI-driven drug discovery, precision medicine breakthroughs, and sustainable (“green”) biomanufacturing are shaping biotech’s next growth cycle. Against a backdrop of geopolitical uncertainty … From Science to Scale: Looking at the Global Biotech Shift in Financing and Infrastructure Read More » To access this post, you must purchase Individual Subscriber Yearly or Enterprise Subscriber.